COSCIENS Biopharma Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • PIPE

  • Financing Rounds
  • 8

  • Investments
  • 5

COSCIENS Biopharma General Information

Description

AEterna Zentaris Inc. is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland which generates key revenue, Ireland, Denmark, and others.

Contact Information

Formerly Known As
AEterna Laboratories, Aeterna Zentaris
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 22 Adelaide Street West
  • Suite 3400
  • Toronto, Ontario M5H 4E3
  • Canada
+1 (780)
Primary Industry
Pharmaceuticals
Corporate Office
  • 22 Adelaide Street West
  • Suite 3400
  • Toronto, Ontario M5H 4E3
  • Canada
+1 (780)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

COSCIENS Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AEterna Zentaris Inc. is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The c
Pharmaceuticals
Toronto, Canada
24 As of 2023

Mumbai, India
 

Nagoya, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

COSCIENS Biopharma Competitors (23)

One of COSCIENS Biopharma’s 23 competitors is Evonile Pharma, a Private Equity-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evonile Pharma Private Equity-Backed Mumbai, India
RaQualia Pharma Formerly PE-Backed Nagoya, Japan
China Resources Pharmaceutical Group Corporation Hong Kong, Hong Kong
Roche Corporation Basel, Switzerland
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 23 competitors. Get the full list »

COSCIENS Biopharma Patents

COSCIENS Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020460118-A1 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin Active 22-Jul-2020
AU-2020460118-B2 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin Active 22-Jul-2020
CA-3185680-A1 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin Pending 22-Jul-2020
EP-4185866-A1 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin Pending 22-Jul-2020
WO-2022017599-A1 A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin Inactive 22-Jul-2020 G01N33/74
To view COSCIENS Biopharma’s complete patent history, request access »

COSCIENS Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

COSCIENS Biopharma Exits (1)

COSCIENS Biopharma’s most recent exit was on 06-Jan-2005 from Echelon Biosciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Echelon Biosciences 06-Jan-2005 Completed
To view COSCIENS Biopharma’s complete exits history, request access »

COSCIENS Biopharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Nualtis Saint-Laurent, Canada 2003

COSCIENS Biopharma FAQs

  • When was COSCIENS Biopharma founded?

    COSCIENS Biopharma was founded in 1990.

  • Where is COSCIENS Biopharma headquartered?

    COSCIENS Biopharma is headquartered in Toronto, Canada.

  • What is the size of COSCIENS Biopharma?

    COSCIENS Biopharma has 24 total employees.

  • What industry is COSCIENS Biopharma in?

    COSCIENS Biopharma’s primary industry is Pharmaceuticals.

  • Is COSCIENS Biopharma a private or public company?

    COSCIENS Biopharma is a Private company.

  • What is COSCIENS Biopharma’s current revenue?

    The current revenue for COSCIENS Biopharma is .

  • How much funding has COSCIENS Biopharma raised over time?

    COSCIENS Biopharma has raised $90.4M.

  • Who are COSCIENS Biopharma’s competitors?

    Evonile Pharma, RaQualia Pharma, China Resources Pharmaceutical Group, Roche, and Novartis are some of the 23 competitors of COSCIENS Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process